Product NDC: | 51285-138 |
Proprietary Name: | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
Non Proprietary Name: | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
Active Ingredient(s): | & nbsp; Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
Administration Route(s): | |
Dosage Form(s): | KIT |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 51285-138 |
Labeler Name: | Teva Women's Health, Inc. |
Product Type: | VACCINE |
FDA Application Number: | BLA125296 |
Marketing Category: | BLA |
Start Marketing Date: | 20110531 |
Package NDC: | 51285-138-50 |
Package Description: | 1 KIT in 1 CARTON (51285-138-50) * 100 TABLET, COATED in 1 BOTTLE (51285-174-02) * 100 TABLET, COATED in 1 BOTTLE (51285-175-02) |
NDC Code | 51285-138-50 |
Proprietary Name | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
Package Description | 1 KIT in 1 CARTON (51285-138-50) * 100 TABLET, COATED in 1 BOTTLE (51285-174-02) * 100 TABLET, COATED in 1 BOTTLE (51285-175-02) |
Product NDC | 51285-138 |
Product Type Name | VACCINE |
Non Proprietary Name | Adenovirus Type 4 and Type 7 Vaccine, Live, Oral |
Dosage Form Name | KIT |
Route Name | |
Start Marketing Date | 20110531 |
Marketing Category Name | BLA |
Labeler Name | Teva Women's Health, Inc. |
Substance Name | |
Strength Number | |
Strength Unit | |
Pharmaceutical Classes |